Evaluation and Long-term Monitoring of Patients with MODY, and Description of Novel Mutations
- 25 August 2022
- journal article
- research article
- Published by Galenos Yayinevi in Journal of Academic Research in Medicine
- Vol. 12 (2) , 99-107
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescentsPediatric Diabetes, 2018
- Monogenic Diabetes Not Caused By Mutations in Mody Genes: A Very Heterogenous Group of DiabetesExperimental and Clinical Endocrinology & Diabetes, 2017
- GCK gene mutations are a common cause of childhood‐onset MODY (maturity‐onset diabetes of the young) in TurkeyClinical Endocrinology, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Phenotypic heterogeneity in monogenic diabetes: The clinical and diagnostic utility of a gene panel-based next-generation sequencing approachMolecular Genetics and Metabolism, 2014
- Prevalence of Vascular Complications Among Patients With Glucokinase Mutations and Prolonged, Mild HyperglycemiaJAMA, 2014
- Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetesDiabetologia, 2013
- Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemiaHuman Mutation, 2009
- A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin‐treated patientsDiabetic Medicine, 2009
- Genetic cause of hyperglycaemia and response to treatment in diabetesThe Lancet, 2003